The Oncology Institute, Inc. (STLN) — Financial Flexibility Index
The Oncology Institute, Inc. (STLN) has a Financial Flexibility Index of 0.06x as of June 2026. Free cash flow of $12.85 Million (operating CF $11.94 Million minus capex $908.00K) represents 0% of total liabilities ($203.15 Million). Explore STLN capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
The Oncology Institute, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for The Oncology Institute, Inc. across 4 annual periods. Check STLN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for The Oncology Institute, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for The Oncology Institute, Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of The Oncology Institute, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-21.39 Million | $-24.59 Million | $180.38 Million | ▲ +11.8% |
| 2024 | -0.13x | $-22.75 Million | $-26.54 Million | $169.13 Million | ▲ +35.5% |
| 2023 | -0.21x | $-31.75 Million | $-36.31 Million | $152.22 Million | ▲ +48.6% |
| 2022 | -0.41x | $-56.23 Million | $-61.76 Million | $138.49 Million | — |